KAKEN PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.8 times, Exceeds Full-Year Plan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Feb 6, 2025 3:30 pm JST Earnings

4521 KAKEN PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KAKEN PHARMACEUTICAL CO.,LTD. <4521> [TSE Prime] announced its financial results after the market closed on February 6th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) surged 2.8 times that of the same period last year, reaching 26 billion yen. The progress rate toward the full-year plan of 21.2 billion yen is 123.0%, already exceeding the target and also exceeding the five-year average of 98.6%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a loss of 4.88 billion yen (compared to a profit of 0.64 billion yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 74.7% from the same period last year, reaching 6.25 billion yen. The operating profit margin jumped from 18.2% in the same period last year to 23.7%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	55,573	12,394	12,976	9,149	243.3	148.7	Feb 3, 2023	J-GAAP
Apr - Dec, 2023	54,685	8,873	9,304	6,675	177.1	93.5	Feb 6, 2024	J-GAAP
Apr - Dec, 2024	75,990	25,420	26,081	19,175	506.3	123.0	Feb 6, 2025	J-GAAP
YoY	+39.0%	+186.5%	+180.3%	+187.3%	+185.9%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	35,873	4,001	4,229	3,957	104.9	75	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	37,128	1,221	1,377	-86	-2.2	75	Nov 8, 2024	J-GAAP
YoY	+3.5%	-69.5%	-67.4%	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	72,984	7,998	8,727	5,440	144.8	150	May 10, 2023	J-GAAP
Mar, 2024	72,044	9,513	9,951	8,025	212.7	150	May 14, 2024	J-GAAP
Mar, 2025 Guidance	88,500	20,800	21,200	14,200	359.9	190	Aug 7, 2024	J-GAAP
YoY	+22.8%	+118.6%	+113.0%	+76.9%	+69.2%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	18,514	3,361	3,582	2,607	69.2	18.2	Feb 6, 2024	J-GAAP
Jan - Mar, 2024	17,359	640	647	1,350	35.8	3.7	May 14, 2024	J-GAAP
Apr - Jun, 2024	18,254	2,750	3,011	1,754	46.3	15.1	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	33,118	16,829	16,812	12,532	330.9	50.8	Nov 8, 2024	J-GAAP
Oct - Dec, 2024	24,618	5,841	6,258	4,889	129.1	23.7	Feb 6, 2025	J-GAAP
YoY	+33.0%	+73.8%	+74.7%	+87.5%	+86.6%